Researchers to Sequence 75,000 Diverse Samples for Rare Genetic Cancer Insights
A large-scale collaborative project is underway to perform whole exome sequencing on nearly 75,000 blood samples from the Multiethnic Cohort (MEC) Study. This initiative involves researchers from the Keck School of Medicine of USC and the University of Hawaiʻi, in partnership with the Regeneron Genetics Center (RGC). The goal is to enhance the precision of cancer risk assessment across diverse populations by identifying rare genetic variations that influence cancer development. The MEC Study, which began in 1993, is a long-term investigation into cancer and chronic disease with over 215,000 participants from Southern California and Hawaiʻi, representing various ethnic backgrounds including African Americans, Japanese Americans, Latinos, Native Hawaiians, and white individuals. This project moves beyond previous genome-wide association studies (GWAS) by focusing on whole exome sequencing, allowing for a more comprehensive analysis of genetic factors. Researchers will also assess copy number variation and ex...